A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes? - Wikidata - awgldk - TriplyDB

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

http://www.wikidata.org/entity/Q48274776

about

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

http://www.wikidata.org/entity/Q48274776

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@en

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@nl

type

label

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@en

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@nl

prefLabel

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@en

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@nl

P1433

Q48274776-5E88D300-F93A-4197-B00D-E0963FC9F91E

P1476

Q48274776-A5985ACF-E9B6-4EAC-B50F-65A77841F087

P2093

Q48274776-C101570E-DE84-41B0-907E-2106D35CF6E1

P2860

Q48274776-6E8F977E-BF4D-41DB-A7C9-C4112892D6E2

Q48274776-7D96FE9A-C494-4249-98B8-979E2FEAF0B2

Q48274776-A354E638-5336-40CC-95F6-52125BAF7E92

Q48274776-B1B331B3-09EE-41EF-AA22-D7F1EB2CC377

Q48274776-D4274C66-7AB1-4E75-AA9D-3AEFA55F8BC8

P304

Q48274776-28358961-D3B9-4E7E-AEC5-5427FCBBB7A7

P31

Q48274776-71657885-8097-4659-8E5B-28D5A76AFA82

P356

Q48274776-8C70B754-F188-4930-B04C-50D3798CD92B

P433

Q48274776-56CD2286-F82D-4FD6-88E5-5D3F3D8A44D8

P478

Q48274776-BE777C0C-FBAE-4038-B624-40140CD9F5DF

P50

Q48274776-59A2F628-D2D8-40A6-8505-CBDBB6A30937

P577

Q48274776-C549359C-66D8-47F4-963E-5919C6AF3883

P698

Q48274776-786DA675-7F7A-4FB3-8A74-A2BC047227B0

P921

Q48274776-E4ED7E75-FA79-4F3C-817C-19F8C610BD00

P356

P1433

Experimental Physiology

P1476

A basis for human QT interval prolongation and arrhythmia risk in type 2 diabetes?

@en

P2093

Jules C Hancox

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time period

Recent advances in understanding sex differences in cardiac repolarization.

The hERG potassium channel and hERG screening for drug-induced torsades de pointes.

Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction.

Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice.

P304

1395-1396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1113/EP086618

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28786529

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes